24 Aug, 2020
The ACI will host their latest in a series of webinars on 22 September, in conjunction with the UK’s leading magazine for the FMCG industry, The Grocer and one of North America’s most established cannabis companies, Columbia Care.
7 Jul, 2020
The ACI will host a series of panels at the upcoming VOXPO virtual event which runs from July 31 to August 2. The ACI are educational partners for the event and our panels will discuss issues relevant to CBD companies and consumers.
19 Jun, 2020
The ACI today announces it will spearhead a CBD Safety Study Consortium to generate data to assess the safety of CBD. This move is in response to calls from regulators around the world who are highlighting the lack of evidence relating to the safety of CBD.
17 Jun, 2020
The ACI today welcomes five new hires to bolster our Regulatory and Compliance Unit. The unit, headed up by Dr Parveen Bhatarah, provides regulatory and compliance support to members of The ACI.
20 May, 2020
The ACI have received clarification from the FSA on several points concerning novel foods dossier applications that have been raised by our members.
14 May, 2020
The ACI announces high-level discussions with the Laboratory of Government Chemists (LGC) that will focus on the development of a cannabinoid testing methodology with a higher precision control, an essential step towards standardisation for the industry.
12 May, 2020
2pm BST, Wednesday 27 May 2020
With the new novel foods regulation deadline looming this event will provide a unique opportunity to listen and engage with representatives of the UK’s regulator the Foods Standards Agency as well as industry experts from trading standards, toxicology, and the analytical testing and legal worlds.
4 May, 2020
The Association for the Cannabinoid Industry today launched a free helpline for CBD companies wanting to continue operations in the UK after the FSA’s deadline of 31 March 2021.
1 May, 2020
The purpose of this timeline is to highlight the importance that CBD companies must start the process of Novel Foods applications now in order to avoid disruption in their distribution channels when FSA regulations come into force. We include the data required in a Novel Foods dossier followed by an estimate of time to produce this data.
27 Apr, 2020
The ACI is pleased to announce the publication of the peer-reviewed academic paper entitled “An Analysis of Over-the-Counter Cannabidiol Products in the United Kingdom”. Two of the paper’s authors are part of the team of experts forming The ACI, Professor Saoirse O’Sullivan and Dr Andy Yates. “In this independent study, we blind tested over the […]
21 Apr, 2020
The ACI congratulate Mile High Labs on the submission of their CBD Novel Foods dossier to the European Food Safety Authority (EFSA) and the UK Food Standards Agency (FSA).
20 Apr, 2020
The Food Standards Agency (FSA) confirmed last week, in a virtual meeting with the Association for the Cannabinoid Industry (The ACI), that they intend to stick to their deadline of 31 March 2021 for CBD companies to have a validated Novel Foods application.
31 Mar, 2020
The ACI today outlined new plans for The ACI Safety Certification programme. Launched exactly one year before the FSA’s new safety regulations come into force, which excludes all CBD food products from sale in the UK without a validated Novel Foods application dossier.
12 Mar, 2020
It has been quite a start to 2020 across our sector, with significant regulatory developments in both the medicinal cannabis and the CBD wellness space.
However, right now we all have to adapt to a new world and the unprecedented challenge a global pandemic presents us all.
11 Mar, 2020
A new YouGov poll commissioned by The Association for the Cannabinoid Industry demonstrates overwhelming support for recent FSA guidance concerning CBD
19 Feb, 2020
Following the FSA’s recent announcement, relating to CBD regulation and precautionary health advice, ACI’s experts have compiled the following FAQ covering the questions consumers, retailers, manufacturers or health care professionals may have concerning CBD.
14 Feb, 2020
In the aftermath of the FSA’s announcement relating to CBD regulation and precautionary health advice, the ACI’s Regulatory Lead, Dr Parveen Bhatarah, has compiled the following answers to some of the common questions being posed to the ACI. Please note: We are also in the process of compiling a more indepth FAQ which we will […]
13 Feb, 2020
The Association for the Cannabinoid Industry (ACI) today welcomes the new regulatory and precautionary advice published by the Food Standards Agency (FSA).
16 Jan, 2020
On the 15th January BBC Two aired a segment on their popular science show Trust Me I’m a Doctor which investigated twelve popular CBD products available in the UK over the counter and online.
19 Dec, 2019
Article 4 is a specific provision which allows companies to consult with competent authorities (e.g. The UK FSA) to establish if the product they wish to sell on the market is in fact novel.
11 Dec, 2019
Steve Moore, ACI Strategic Counsel has today responded to the National Pharmacy Association’s advisory statement regarding CBD products in pharmacies with the following statement:
10 Dec, 2019
Deadline for acknowledgement of engagement from ACI members in the Novel Foods application process set to 20 December. This is the first major step towards a fully-compliant CBD industry in the UK.
3 Dec, 2019
The Association for the Cannabinoid Industry (ACI) is delighted to announce its partnership with The Grocer as a diamond sponsor for the publication’s first ever CBD Global Summit on the 16th-17th March 2020.
3 Dec, 2019
Following the successful launch of the ACI in November 2019, the ACI has announced plans to host evening briefing sessions for prospective new members.
20 Nov, 2019
Friday 8th November saw the launch of a ground-breaking new industry body to foster a legally compliant, socially responsible and innovative cannabinoid industry – The Association for the Cannabinoid Industry (ACI).